{
  "schema_version": "1.0.0",
  "stage": "discovery",
  "agent_metadata": {
    "agent_id": "research-discovery",
    "session_id": "episode_004_20250829",
    "execution_timestamp": "2025-08-29T11:30:00Z",
    "episode_context": {
      "episode_number": 4,
      "topic": "CRISPR Gene Editing Ethics - Multi-Perspective Analysis",
      "target_duration_minutes": 15,
      "special_focus": "multi_perspective_analysis_validation"
    }
  },
  "cost_tracking": {
    "execution_cost": 0.25,
    "budget_allocated": 0.25,
    "budget_remaining": 0.00,
    "query_count": 1
  },
  "execution_status": {
    "status": "completed",
    "completion_timestamp": "2025-08-29T11:30:00Z",
    "quality_gate_status": "passed"
  },
  "discovery_findings": {
    "priority_investigation_areas": [
      {
        "area_id": "ethical_frameworks",
        "area_name": "Ethical Frameworks for Gene Editing",
        "priority_level": "critical",
        "rationale": "Multiple philosophical traditions offer different approaches to CRISPR ethics - essential for balanced analysis",
        "key_concepts": ["utilitarian outcomes", "deontological duties", "virtue ethics", "justice/equality", "religious perspectives", "procedural ethics"],
        "complexity_level": "high"
      },
      {
        "area_id": "stakeholder_perspectives",
        "area_name": "Multi-Stakeholder Viewpoints",
        "priority_level": "critical",
        "rationale": "Diverse stakeholders have fundamentally different concerns and values regarding gene editing",
        "key_concepts": ["scientists", "bioethicists", "religious leaders", "disability advocates", "patients", "regulatory bodies"],
        "complexity_level": "high"
      },
      {
        "area_id": "current_controversies",
        "area_name": "Active Areas of Expert Disagreement",
        "priority_level": "high",
        "rationale": "Ongoing debates reveal uncertainty and complexity in ethical analysis",
        "key_concepts": ["germline editing", "regulation moratoria", "safety efficacy", "justice accessibility", "naturalness debate"],
        "complexity_level": "high"
      },
      {
        "area_id": "recent_developments",
        "area_name": "2024-2025 CRISPR Ethics Developments",
        "priority_level": "high",
        "rationale": "Recent policy calls, research findings, and ethical discussions provide current context",
        "key_concepts": ["ten-year ban proposals", "social responsibility discourse", "patient participation", "international coordination"],
        "complexity_level": "medium"
      }
    ],
    "expert_identification": {
      "primary_experts": [
        {
          "expert_id": "doudna_jennifer",
          "name": "Jennifer Doudna",
          "credentials": "Nobel laureate, co-inventor CRISPR-Cas9, molecular biologist",
          "perspective_focus": "scientific innovation with ethical responsibility",
          "intellectual_humility_indicators": ["actively engaged in policy/ethics discussions", "acknowledges technical limitations"],
          "priority_level": "critical"
        },
        {
          "expert_id": "baylis_francoise",
          "name": "Fran√ßoise Baylis",
          "credentials": "Bioethicist, philosopher",
          "perspective_focus": "justice, equality, pluralism in germline editing",
          "intellectual_humility_indicators": ["emphasizes uncertainty", "advocates inclusive deliberation"],
          "priority_level": "critical"
        },
        {
          "expert_id": "hurlbut_benjamin",
          "name": "J. Benjamin Hurlbut",
          "credentials": "Science policy scholar",
          "perspective_focus": "governance, public deliberation, innovation caution",
          "intellectual_humility_indicators": ["emphasizes procedural uncertainty", "advocates for democratic deliberation"],
          "priority_level": "critical"
        },
        {
          "expert_id": "kirksey_eben",
          "name": "Eben Kirksey",
          "credentials": "Anthropologist",
          "perspective_focus": "disability rights, patient perspectives, community engagement",
          "intellectual_humility_indicators": ["centers community voices", "acknowledges complexity of patient experiences"],
          "priority_level": "high"
        },
        {
          "expert_id": "kimmelman_jonathan",
          "name": "Jonathan Kimmelman",
          "credentials": "Clinical trial ethicist",
          "perspective_focus": "translational research ethics, risk assessment",
          "intellectual_humility_indicators": ["emphasizes methodological uncertainty", "advocates for cautious progression"],
          "priority_level": "high"
        }
      ],
      "secondary_experts": [
        {
          "expert_id": "biswas_irfan",
          "name": "Irfan Biswas",
          "credentials": "Social responsibility researcher",
          "perspective_focus": "collective governance, global coordination",
          "priority_level": "medium"
        },
        {
          "expert_id": "parikh_manav",
          "name": "Manav C. Parikh",
          "credentials": "Legal scholar, bioethics researcher",
          "perspective_focus": "germline editing legal frameworks",
          "priority_level": "medium"
        }
      ]
    },
    "research_methodology_priorities": [
      {
        "method": "multi_framework_analysis",
        "description": "Analyze each ethical dilemma through multiple philosophical lenses",
        "budget_allocation": 0.30
      },
      {
        "method": "stakeholder_voice_integration",
        "description": "Ensure authentic representation of diverse stakeholder perspectives",
        "budget_allocation": 0.25
      },
      {
        "method": "controversy_mapping",
        "description": "Document areas of expert disagreement and ongoing uncertainty",
        "budget_allocation": 0.20
      },
      {
        "method": "current_context_analysis",
        "description": "Focus on 2024-2025 developments and emerging debates",
        "budget_allocation": 0.25
      }
    ],
    "intellectual_humility_focus_areas": [
      {
        "area": "expert_uncertainty_admissions",
        "description": "Statements where experts acknowledge what they don't know or can't predict",
        "examples": ["safety timeline uncertainties", "long-term societal impacts", "regulatory effectiveness"]
      },
      {
        "area": "value_pluralism_recognition",
        "description": "Acknowledgment that different stakeholders hold legitimate but conflicting values",
        "examples": ["disability rights vs curative approach", "individual autonomy vs collective good"]
      },
      {
        "area": "methodological_limitations",
        "description": "Recognition of limitations in current ethical analysis methods",
        "examples": ["difficulty predicting social impacts", "challenges in global coordination"]
      }
    ]
  },
  "budget_optimization": {
    "deep_dive_allocation": 1.00,
    "priority_distribution": {
      "ethical_frameworks": 0.30,
      "stakeholder_perspectives": 0.30,
      "expert_disagreements": 0.25,
      "recent_developments": 0.15
    }
  },
  "quality_assurance": {
    "expert_diversity_score": 0.9,
    "perspective_balance_score": 0.85,
    "intellectual_humility_focus": 0.9,
    "current_relevance_score": 0.9,
    "research_depth_potential": 0.88
  }
}
